Free Trial

2,300 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by Freemont Management S.A.

Axon Enterprise logo with Aerospace background
Remove Ads

Freemont Management S.A. purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,300 shares of the biotechnology company's stock, valued at approximately $1,367,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Prestige Wealth Management Group LLC lifted its stake in shares of Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock worth $33,000 after purchasing an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise during the fourth quarter worth about $40,000. Brooklyn Investment Group acquired a new position in shares of Axon Enterprise during the third quarter worth about $41,000. Y.D. More Investments Ltd acquired a new position in shares of Axon Enterprise during the fourth quarter worth about $45,000. Finally, Stonebridge Financial Group LLC acquired a new position in shares of Axon Enterprise during the fourth quarter worth about $53,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Insider Activity

In other news, insider Jeffrey C. Kunins sold 1,035 shares of the company's stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the completion of the transaction, the insider now directly owns 124,243 shares of the company's stock, valued at approximately $77,586,026.21. This represents a 0.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company's stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,792 shares of company stock valued at $1,087,843. 5.70% of the stock is currently owned by insiders.

Remove Ads

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. The Goldman Sachs Group boosted their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research note on Monday, January 27th. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Needham & Company LLC reiterated a "buy" rating and issued a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 26th. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Finally, Morgan Stanley upgraded Axon Enterprise from an "equal weight" rating to an "overweight" rating and boosted their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $604.67.

Read Our Latest Research Report on Axon Enterprise

Axon Enterprise Stock Up 0.3 %

Axon Enterprise stock traded up $1.59 during midday trading on Friday, hitting $560.00. The stock had a trading volume of 802,214 shares, compared to its average volume of 845,276. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a market cap of $42.91 billion, a P/E ratio of 144.70, a P/E/G ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The business has a fifty day moving average price of $591.90 and a 200 day moving average price of $540.96.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Read More

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

7 Stocks to Benefit From Trump’s Tariffs in 2025

7 Stocks to Benefit From Trump’s Tariffs in 2025

While the impact of these tariffs remains uncertain, some stocks are positioned to thrive under these policies; check out these 7 stock picks now.

Recent Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads